Physician profile
Anay Rajendra Patel
NPI 1588897011
$191,201.82
in general payments reported to CMS, 2019-2025
7 companies · $101K in 2025
The $101K reported for 2025 was more than what 92% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,682 · 2020: $971 · 2021: $11K · 2022: $15K · 2023: $7,104 · 2024: $52K · 2025: $101K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $155K · Travel and Lodging: $4,256 · Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $155,220.59 |
| Travel and Lodging | $4,255.62 |
| Food and Beverage | $1,278.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $170,205.10 | 2019-2025 | Reclaim, Pinnacle, Pinnacle Gription Tf |
| Depuy Synthes Products, INC. | $19,414.00 | 2019-2025 | Kincise, Velys |
| Depuy Synthes Sales INC. | $1,012.41 | 2020-2023 | Actis |
| Stryker Corporation | $420.13 | 2019-2023 | Mako |
| Spinal Elements, INC. | $115.54 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $22.73 | 2024 | |
| Merck Sharp & Dohme LLC | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.